USP “Key Drug Types” Could Serve As CMS Standard For Medicare Rx Plans
Executive Summary
The U.S. Pharmacopeia hopes its list of "formulary key drug types" will become the CMS standard for reviewing the appropriateness of Medicare Rx plans' drug lists
You may also be interested in...
Medicare Formularies Should Contain “Majority” Of Drugs In Six Classes
Medicare drug plan formularies will be expected to cover the "majority" of products in six specific drug classes, the Centers for Medicare & Medicaid Services final formulary review guidelines state
Medicare Formularies Should Contain “Majority” Of Drugs In Six Classes
Medicare drug plan formularies will be expected to cover the "majority" of products in six specific drug classes, the Centers for Medicare & Medicaid Services final formulary review guidelines state
USP Final Formulary Guide Adds PPI Class, But Has Few Other Changes
Proton pump inhibitors may be the only commercially significant group of drugs to gain "pharmacologic class" status in the revisions to U.S. Pharmacopeia's model guidelines for Medicare drug plans